BioSpace News Archive

The number of residents in senior living communities who reported always feeling lonely more than doubled during the pandemic, according to a new research report released today by iN2L, the leading provider of person-centered digital engagement to the senior living market

Catherine “Cathy” Kotz, PhD, FTOS, a leading researcher into the neuroscience of obesity and energy balance is the new president of The Obesity Society (TOS), the organization announced today.

- Aditum Bio “spin-out” companies such as Anteris Bio will leverage TrialSpark’s clinical development engine to rapidly advance their drug assets through clinical trials.

MTF Biologics’ SomaGen ® Meshed and Leneva ® Allografts Receive American Podiatric Medical Association Seal of Approval APMA Seal of Approval signals to physicians and clinicians that MTF Biologics ® tissues are beneficial to foot health EDISON, N.J.--( BUSINESS WIRE )-- MTF Biologics ® has received the coveted American Podiatric Medical Association (APMA) Seal of Approval for two MTF Biologics Wound Care tissues, SomaGen ® Meshed, Allograft

The Prostate Cancer Foundation (PCF) and Cancer Research Innovation in Science (CRIS) today announced two new CRIS Cancer Foundation-PCF Young Investigator Awards. The awards, each in the amount of $250,000 , are granted to future research leaders at two of the United Kingdom’s leading cancer research institutions who will keep th

Loki Therapeutics, an immuno-oncology company developing next-generation cancer therapeutics that leverage childhood vaccination recall antigens, announced today its Chief Executive Officer Chris Bradley will participate in Biotech Showcase Digital and BIO @ JPM being held January 11-15, 2021 . Details of the events

Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, today announced that it has been awarded funding in the amount of approximately $1M by the National Institute of Health (NIH) Rapid Acceleration of Diagnostics (RADxSM) initiative, to expedite the launch of the company’s SARS-CoV-2 molecular diagnostic test on the Revogene® platform.

Aerus Medical formally announced the start of a double-blind two-year clinical study to evaluate the impact the Aerus Medical Guardian with ActivePure Technology can have on reducing nosocomial infections, or healthcare-associated infections, also known as HAIs, from surgical operating room procedures. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201216005947

IQVIA™ (NYSE:IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced a collaboration with Servier, an independent global pharmaceutical company, to reinvent their R&D clinical development processes and support their long-term R&D success. Servier has ambitious plans for growth a

Technical Resources International, Inc. (TRI) has been awarded the Clinical Studies Network (CSN) Clinical Trial Planning and Execution (CTPE) Contract in support of the Biomedical Advanced Research and Development Authority (BARDA), which is part of the U.S. Department of Health and Human Services (HHS) Office of the Assistant Sec